Prior and concurrent use of abiraterone and enzalutamide with Ra-223 in an expanded access setting. Sartor, A., Fernandez, D., Morris, M. J., Iagaru, A., Brown, A., Almeida, F., Sweeney, C., Smith, M., Dicker, A., Wong, Y., Shore, N. D., Gratt, J., Petrenciuc, O., Vogelzang, N. J. AMER SOC CLINICAL ONCOLOGY. 2015

View details for DOI 10.1200/jco.2015.33.7_suppl.253

View details for Web of Science ID 000356886700254